ARWR · Arrowhead Pharmaceuticals, Inc. · Share Buybacks
$44.63
-3.15 (-6.59%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q4 2026 earnings call transcript
Market Cap
$6.75B
Shares
141.37M
Volume · Nov 16
844.9K
Avg daily vol (3M)
1.92M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-12-02 | — | $250,000,000 | — | — | 10-K , filed 2025-11-25 |
Key facts
CIK
879407
CUSIP
04280A100
13F (30d)
365 filings
343 filers
Visit website
Investor relations